Vancomycin hydrochloride and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vancomycin hydrochloride (vancomycin hydrochloride) and Bumetanide (bumetanide). Common drug interactions include white blood cell count decreased among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Vancomycin hydrochloride and Bumetanide. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Vancomycin hydrochloride?

Vancomycin hydrochloride has active ingredients of vancomycin hydrochloride. It is often used in mrsa infection. eHealthMe is studying from 8,399 Vancomycin hydrochloride users. Check the latest studies of Vancomycin hydrochloride.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

22 people who take Vancomycin hydrochloride and Bumetanide together, and have interactions are studied.

Vancomycin hydrochloride and Bumetanide drug interactions.

What are the common drug interactions of Vancomycin Hydrochloride and Bumetanide, by gender? *:

female:

  1. White blood cell count decreased
  2. Chronic graft versus host disease in skin (damage by immune cells to skin after grafting)
  3. Mania (a state of abnormally elevated or irritable mood)
  4. Pneumonia fungal
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  7. Skin lesion
  8. Staphylococcal bacteraemia (a bacterial infection of blood)
  9. Urinary tract infection
  10. Abscess intestinal (collections of pus-intestinal)

male:

  1. Asthenia (weakness)
  2. Dizziness
  3. Arthralgia (joint pain)
  4. Back pain
  5. Blood glucose increased
  6. Breath sounds
  7. Catheter site discharge
  8. Chest discomfort
  9. Chest pain
  10. Constipation

What are the common drug interactions of Vancomycin Hydrochloride and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood creatine phosphokinase increased
  2. Blood lactate dehydrogenase increased
  3. Hyperpyrexia (extremely high fever)
  4. Paresis (a condition of muscular weakness)
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  6. Urine discolouration

50-59:

  1. Acute respiratory failure
  2. Anaemia (lack of blood)
  3. Asthenia (weakness)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Cardiomegaly (increased size of heart than normal)
  6. Cardiorenal syndrome (kidney failure and heart failure)
  7. Confusional state
  8. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  9. Epistaxis (bleed from the nose)
  10. Gangrene (body tissue dies)

60+:

  1. Anaemia (lack of blood)
  2. Blood potassium decreased
  3. Anti-platelet antibody positive
  4. Blood disorder
  5. Gastrointestinal neoplasm (cancer tumour of digestive tract)
  6. Haemoglobin decreased
  7. Surgery
  8. Therapeutic response decreased (less preventive response)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Tumour haemorrhage (bleeding from tumour)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 5 people, 22.73%
  2. Immunodeficiency Common Variable: 4 people, 18.18%
  3. Dehydration (dryness resulting from the removal of water): 4 people, 18.18%
  4. Respiratory Disorder (respiratory disease): 3 people, 13.64%
  5. Anaesthesia: 3 people, 13.64%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
  7. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 9.09%
  8. Back Pain: 2 people, 9.09%
  9. Constipation: 2 people, 9.09%
  10. Diarrhea: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin hydrochloride and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vancomycin hydrochloride and Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vancomycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vancomycin hydrochloride and bumetanide (the active ingredients of Vancomycin hydrochloride and Bumetanide, respectively), and Vancomycin hydrochloride and Bumetanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: